Fujifilm, Exact Sciences & more: 4 GI company key notes
Here are four updates from gastroenterology companies this past week:
Five healthcare facilities recently signed on to adopt Fujifilm's Eluxeo Endoscopic Visualization System, including two endoscopy centers and an ASC.
A phase 1 clinical trial found that Landos Biopharma's Crohn's disease and ulcerative colitis treatment, BT-11, was well-tolerated with no dose-limiting toxicities or detectable systemic immunosuppression.
Modernizing Medicine Gastroenterology improved its gGastro EHR through a collaboration with Change Healthcare.
Exact Sciences' Cologuard can improve colorectal cancer screening rates, according to a study published in Gastroenterology.
More articles on gastroenterology:
15 ASC company executive moves in 2019
12 ASC leadership tips — Delegation, change management & more
Mississippi clinic honors ASC nurse for going the extra mile — 3 highlights
© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.